Status:
COMPLETED
Assessment of Factors That Affected Respiratory Parameters in Mucopolysaccharidoses Patients
Lead Sponsor:
Hacettepe University
Conditions:
Mucopolysaccharidoses
Eligibility:
All Genders
7-30 years
Brief Summary
Respiratory system affects in mucopolysaccharidosis (MPS) disease. Respiratory system symptoms are seen in almost every MPS patients and respiratory failure is one of the most common causes of death i...
Detailed Description
This study was participated MPS patients. Patients' pulmonary function test, functional capacity, respiratory muscle strength and endurance, peak cough flow was assessed and recorded. Pulmonary funct...
Eligibility Criteria
Inclusion
- People who diagnosed Mucopolysaccharidoses disease in Hacettepe University.
- Cooperation
Exclusion
- Patients who were not walking ability.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04491747
Start Date
February 1 2019
End Date
February 1 2020
Last Update
July 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Ankara, Turkey (Türkiye)